RespireRx Pharmaceuticals Market Cap

RespireRx Pharmaceuticals has a market cap or net worth of $365.42 thousand as of July 22, 2024. Its market cap has decreased by -82.60% in one year.

Market Cap

365.42K

Enterprise Value

2.57M

1-Year Change

-82.60%

Ranking

n/a

Market Cap Chart

Since December 1, 1998, RespireRx Pharmaceuticals's market cap has decreased from $3.90M to $365.42K, a decrease of -90.63%. That is a compound annual growth rate of -9.71%.

Market Cap History

Date	Market Cap	% Change
Feb 2, 2022	1.30M	18.18%
Dec 31, 2021	1.10M	-42.11%
Dec 31, 2020	1.90M	375.00%
Dec 31, 2019	400.00K	-82.61%
Dec 31, 2018	2.30M	-23.33%
Dec 29, 2017	3.00M	-47.37%
Dec 30, 2016	5.70M	-41.84%
Dec 31, 2015	9.80M	36.11%
Dec 31, 2014	7.20M	67.44%
Dec 31, 2013	4.30M	-
Dec 31, 2012	4.30M	-
Dec 30, 2011	4.30M	-67.91%
Dec 31, 2010	13.40M	97.06%
Dec 31, 2009	6.80M	-74.91%
Dec 31, 2008	27.10M	13.87%
Dec 31, 2007	23.80M	-45.54%
Dec 29, 2006	43.70M	-41.58%
Dec 30, 2005	74.80M	-2.98%
Dec 31, 2004	77.10M	43.58%
Dec 31, 2003	53.70M	406.60%
Dec 31, 2002	10.60M	-75.29%
Dec 31, 2001	42.90M	68.90%
Dec 29, 2000	25.40M	126.79%
Dec 31, 1999	11.20M	36.59%
Dec 31, 1998	8.20M	110.26%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	814.94B
Novo Nordisk	579.91B
UnitedHealth Group	520.32B
Johnson & Johnson	372.29B
Merck & Co.	318.55B
AbbVie	304.29B
AstraZeneca	244.04B
Novartis AG	207.64B

Market Cap Rankings